2018\u5e743\u670819\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001\u773c\u79d1\u95a2\u9023\u696d\u754c\u306e\u6700\u5927\u624bCRO\u3067\u3042\u308bOra, Inc.\u793e\uff08\u4ee5\u4e0bOra\u793e\uff09\u304c\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b7\u30b9\u30c6\u30e0\u3084\u30d7\u30ed\u30bb\u30b9\u3092\u7d71\u5408\u5316\u3059\u308b\u305f\u3081³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/a><\/strong>\u3092\u63a1\u7528\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002Ora\u793e\u306f\u3001CTMS\u3001eTMF\u304a\u3088\u3073study start-up\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u7fa4\u3092\u5358\u4e00\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u307e\u3068\u3081\u308b\u3053\u3068\u3067\u3001\u81e8\u5e8a\u8a66\u9a13\u5168\u4f53\u306e\u696d\u52d9\u306e\u52b9\u7387\u5316\u3068\u53ef\u8996\u6027\u3092\u5411\u4e0a\u3067\u304d\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308aOra\u793e\u306f\u3001\u5185\u90e8\u306e\u95a2\u4fc2\u8005\u3068\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u306e\u9023\u643a\u3092\u62e1\u5927\u3057\u3066\u3001\u30b5\u30fc\u30d3\u30b9\u306e\u63d0\u4f9b\u3092\u8fc5\u901f\u5316\u3057\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u8cea\u3092\u9ad8\u3081\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n <\/p>\n Ora\u793e\u306e\u30af\u30ea\u30cb\u30ab\u30eb\u30a4\u30f3\u30d5\u30a9\u30e1\u30fc\u30b7\u30e7\u30f3\u30b7\u30b9\u30c6\u30e0\u30de\u30cd\u30b8\u30e3\u30fc\u3001Edward Leftin\u6c0f\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u79c1\u305f\u3061\u306b\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5408\u7406\u5316\u3059\u308b\u65b0\u3057\u3044\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304c\u5fc5\u8981\u3067\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ\u306e\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u958b\u767a\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u306e\u304a\u304b\u3052\u3067\u3001\u5f53\u793e\u306e\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306f\u4f5c\u696d\u52b9\u7387\u3092\u6539\u5584\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3057\u305f\u3002\u73fe\u5728\u3067\u306f\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u304a\u3051\u308b\u8a66\u9a13\u306e\u958b\u59cb\u304b\u3089\u7d42\u4e86\u307e\u3067\u306e\u3042\u3089\u3086\u308b\u30d7\u30ed\u30bb\u30b9\u3068\u60c5\u5831\u3092\u7ba1\u7406\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u300d<\/p>\n Ora\u793e\u306e\u7d71\u5408\u3055\u308c\u305f\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u79fb\u884c\u306f\u3001³Ô¹Ï±¬ÁÏ Vault eTMF<\/a><\/strong>\u304b\u3089\u59cb\u307e\u308a\u307e\u3057\u305f\u3002\u3053\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u3001TMF\u306e\u751f\u6210\u3068\u540c\u6642\u306b\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306b\u3088\u308b\u6587\u66f8\u3084\u30d7\u30ed\u30bb\u30b9\u306e\u7ba1\u7406\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u3067\u652f\u63f4\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u3001\u67fb\u5bdf\u306b\u5bfe\u3059\u308b\u6e96\u5099\u3092\u6574\u3048\u308b\u3068\u3068\u3082\u306b\u3001\u8a66\u9a13\u306e\u7d42\u4e86\u306b\u304b\u304b\u308b\u671f\u9593\u3092\u6570\u9031\u9593\u304b\u3089\u6570\u65e5\u9593\u306b\u307e\u3067\u77ed\u7e2e\u3057\u307e\u3059\u3002\u307e\u305fOra\u793e\u306f\u3001³Ô¹Ï±¬ÁÏ Vault Study Startup<\/strong><\/a><\/strong>\u306e\u8ffd\u52a0\u306b\u3088\u308a\u3001\u4e16\u754c\u4e2d\u306e\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u9078\u5b9a\u3068\u8a66\u9a13\u958b\u59cb\u307e\u3067\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u8fc5\u901f\u5316\u3067\u304d\u305f\u307b\u304b\u3001\u81e8\u5e8a\u8a66\u9a13\u30c1\u30fc\u30e0\u306f³Ô¹Ï±¬ÁÏ Vault CTMS<\/a><\/strong>\u306b\u3088\u308a\u3001\u8a66\u9a13\u306e\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u3092\u901a\u3058\u3066\u5f93\u6765\u3088\u308a\u3082\u6709\u7528\u306a\u77e5\u898b\u3092\u7372\u5f97\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u30d7\u30ed\u30a2\u30af\u30c6\u30a3\u30d6\u306a\u81e8\u5e8a\u8a66\u9a13\u306e\u7ba1\u7406\u3092\u5b9f\u65bd\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Vault Clinical Suite\u306f\u3001\u5404\u30c1\u30fc\u30e0\u304c\u540c\u3058\u8a66\u9a13\u6587\u66f8\u3084\u30c7\u30fc\u30bf\u3092\u5171\u6709\u3067\u304d\u308b\u3088\u3046\u652f\u63f4\u3059\u308b\u3053\u3068\u3067\u3001\u3088\u308a\u826f\u3044\u610f\u601d\u6c7a\u5b9a\u3092\u884c\u3048\u308b\u3088\u3046\u306b\u3057\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001Vault CTMS\u3084Vault Study Startup\u3067\u4f5c\u6210\u30fb\u767b\u9332\u3055\u308c\u305f\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u5831\u544a\u66f8\u3084CV\u306a\u3069\u306e\u6587\u66f8\u306f\u3001\u81ea\u52d5\u7684\u306bTMF\u306e\u4e00\u90e8\u306b\u306a\u308a\u307e\u3059\u3002\u3053\u3046\u3057\u3066\u624b\u52d5\u306e\u30b9\u30c6\u30c3\u30d7\u3092\u6e1b\u3089\u3059\u4e00\u65b9\u3067\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3092\u542b\u3080\u8907\u6570\u7d44\u7e54\u306e\u30c1\u30fc\u30e0\u304c\u3001\u60c5\u5831\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u6d3b\u7528\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ\u306e³Ô¹Ï±¬ÁÏ Vault\u62c5\u5f53\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Jennifer Goldsmith\u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300cCRO\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3057\u3001\u6cbb\u9a13\u4f9d\u983c\u8005\u3068\u306e\u9593\u3067\u4eca\u307e\u3067\u4ee5\u4e0a\u306b\u5354\u50cd\u7684\u30fb\u6226\u7565\u7684\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3092\u7bc9\u304f\u65b9\u5411\u3078\u5411\u304b\u3046\u696d\u754c\u5168\u4f53\u306e\u30c8\u30ec\u30f3\u30c9\u3092\u30ea\u30fc\u30c9\u3057\u3066\u3044\u307e\u3059\u3002Ora\u793e\u306f\u3001³Ô¹Ï±¬ÁÏ Vault Clinical Suite\u3067\u3069\u306e\u3088\u3046\u306b\u30b7\u30b9\u30c6\u30e0\u3068\u30d7\u30ed\u30bb\u30b9\u9593\u306e\u969c\u58c1\u3092\u6253\u958b\u3057\u3001\u8a66\u9a13\u5b9f\u65bd\u306e\u52b9\u7387\u5316\u3068\u54c1\u8cea\u306e\u6539\u5584\u3067\u304d\u308b\u306e\u304b\u3001\u6a21\u7bc4\u7684\u306a\u4e8b\u4f8b\u3092\u793a\u3057\u3066\u304f\u308c\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n Vault CTMS\u3001Vault eTMF\u3001\u304a\u3088\u3073Vault Study Startup\u306f³Ô¹Ï±¬ÁÏ Vault Clinical Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3001EDC\u3001CTMS\u3001eTMF\u304a\u3088\u3073study start-up\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u7fa4\u3092\u4e00\u3064\u306b\u307e\u3068\u3081\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3068\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3059\u308b\u696d\u754c\u521d\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Vault Clinical\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u73fe\u5728\u3001\u4e16\u754c\u7684\u306b\u4e8b\u696d\u5c55\u958b\u3057\u3066\u3044\u308b\u30d0\u30a4\u30aa\u533b\u85ac\u54c1\u4f01\u696d\u306e\u4e0a\u4f4d20\u793e\u306e\u3046\u30618\u793e\u3092\u542b\u3080\u3001170\u793e\u3092\u8d85\u3048\u308b\u304a\u5ba2\u69d8\u306b\u3054\u5229\u7528\u3044\u305f\u3060\u3044\u3066\u3044\u307e\u3059\u3002<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011 \u3010Forward-looking Statements\u3011<\/strong> 2018\u5e743\u670819\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-41280","post","type-post","status-publish","format-standard","hentry","category-press-release","blog-product-content-management","blog-product-veeva-rd","blog-product-veeva-vault"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41280"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=41280"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41280\/revisions"}],"predecessor-version":[{"id":41283,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/41280\/revisions\/41283"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=41280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=41280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=41280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n<\/strong>³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067600\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2017. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"